Trial Profile
Phase II Double-Blind Placebo-Controlled Dose Finding Study to Evaluate Safety/Efficacy of Ipamorelin Compared to Placebo for Recovery of Gastrointestinal Function in Patients Following Small or Large Bowel Resection w/Primary Anastomosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Ipamorelin (Primary)
- Indications Gastrointestinal motility disorders
- Focus Therapeutic Use
- Sponsors Helsinn Therapeutics
- 04 Jun 2014 New trial record